ZyVersa

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZyVersa and other ETFs, options, and stocks.

About ZVSA

ZyVersa Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It develops drugs for the treatment of renal and inflammatory diseases. 

CEO
Stephen C. Glover
CEOStephen C. Glover
Employees
7
Employees7
Headquarters
Weston, Florida
HeadquartersWeston, Florida
Founded
2014
Founded2014
Employees
7
Employees7

ZVSA Key Statistics

Market cap
2.53M
Market cap2.53M
Price-Earnings ratio
-0.07
Price-Earnings ratio-0.07
Dividend yield
Dividend yield
Average volume
7.16M
Average volume7.16M
High today
$0.5305
High today$0.5305
Low today
$0.48
Low today$0.48
Open price
$0.4985
Open price$0.4985
Volume
118.43K
Volume118.43K
52 Week high
$6.30
52 Week high$6.30
52 Week low
$0.4728
52 Week low$0.4728

People also own

Based on the portfolios of people who own ZVSA. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.